Loading…

Modified EPOCH for high‐risk non‐Hodgkin lymphoma in sub‐Saharan Africa

Aggressive non‐Hodgkin lymphoma (NHL) is among the most common cancers in sub‐Saharan Africa (SSA), where CHOP is standard treatment and outcomes are poor. To address this, we treated 17 newly diagnosed adult patients in Malawi with Burkitt (n = 8), plasmablastic (n = 8), and primary effusion lympho...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2020-01, Vol.9 (1), p.77-83
Main Authors: Zuze, Takondwa, Ellis, Grace K., Kasonkanji, Edwards, Kaimila, Bongani, Nyasosela, Richard, Nyirenda, Ruth, Tomoka, Tamiwe, Mulenga, Maurice, Chikasema, Maria, Tewete, Blessings, Mtangwanika, Asekanadziwa, Chiyoyola, Sarah, Chimzimu, Fred, Kampani, Coxcilly, Mhango, Wilberforce, Nicholas, Simon, Randall, Cara, Montgomery, Nathan D., Fedoriw, George, Westmoreland, Katherine D., Painschab, Matthew S., Gopal, Satish
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aggressive non‐Hodgkin lymphoma (NHL) is among the most common cancers in sub‐Saharan Africa (SSA), where CHOP is standard treatment and outcomes are poor. To address this, we treated 17 newly diagnosed adult patients in Malawi with Burkitt (n = 8), plasmablastic (n = 8), and primary effusion lymphoma (n = 1) with a modified EPOCH regimen between 2016 and 2019. Twelve patients (71%) were male and the median age was 40 years (range 16‐63). Eleven (65%) were HIV infected, median CD4 count was 218 cells/µL (range 9‐460), and nine (82%) had suppressed HIV RNA 
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.2631